These findings highlight GLMP as a key intermediary in lipid metabolic regulation via the PI3K/AKT pathway, with BRG1 acting as an upstream modulator, offering new avenues for metabolic targeting in HCC. The gene discussed is PIK3CB; the disease is hepatocellular carcinoma.